Detail akcie Kenvue Rg online

Business Summary: Kenvue Inc. is a consumer health company. The Company’s differentiated portfolio of brands includes Tylenol, Neutrogena, Listerine, Johnson’s, BAND-AID, Aveeno, Zyrtec, and Nicorette. It operates through three segments: Self Care, Skin Health and Beauty, and Essential Health. Its Self Care product categories include pain care; cough, cold, and allergy; digestive health; smoking cessation; eye care; and other products. Self Care segments include brands such as Tylenol, Motrin, Nicorette, Benadryl, Zyrtec, Zarbee’s, ORSLTM, Rhinocort, and Calpol. The Skin Health and Beauty segment is focused on face and body care, as well as hair, sun, and other products. The Essential Health segment includes oral care, baby care, women’s health, wound care, and other products. Its portfolio includes Self Care, Skin Health and Beauty, and Essential Health products which connect with consumers across North America, Asia Pacific (APAC), Europe, Middle East, and Africa (EMEA), and Latin America (LATAM).
Financial Summary: BRIEF: For the 39 weeks ended 28 September 2025, Kenvue Inc revenues decreased 4% to $11.34B. Net income increased 55% to $1.14B. Revenues reflect Self Care segment decrease of 68% to $1.56B, Essential Health segment decrease of 68% to $1.16B, Skin Health and Beauty segment decrease of 68% to $1.04B. Net income reflects Unallocated segment loss decrease of 81% to $335M. Dividend per share increased from $0.61 to $0.62.